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Abstract. Mimicking Nature, supramolecular chemistry represents 
the chemistry beyond the molecule, in view that intermolecular 
interactions constitute the driving force for the preparation of 
molecular and supramolecular assemblies, using the chemical 
information contained in molecular building blocks. Upon 
molecular recognition between discrete units, chemical processes 
such as self-assembly and self-organisation start operating, and          
are the leading processes to build up supramolecular aggregates 
and materials. When those materials have dimensions on the 
nanometric scale, a recently emerging scientific discipline is defined, 
Nanoscience. Nanomaterials are promising tools for many 
applications, and their use in biomedical and clinical applications 
defines the so-called Nanomedicine. In this review we present a 
few selected examples of nanomaterials designed for therapeutical 
purposes, emphasizing the importance of the preparation methodology 
in terms of their therapeutical use.  
  
Introduction 
 
 Nanoscience frames the study, manipulation and control of chemical 
and/or biological materials at the nanoscale, which correspond to structures 
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or systems with dimensions within the range of 1 to 100 nm (1 nm = 10-9 m) [1]. 
Within such nanoscale we could include supramolecular biological systems, such 
as cell membranes, nucleic acids or proteins, as well as supramolecular artificial 
nanoestructured materials; amongst them, carbon nanotubes, liquid crystals, self-
assembled monolayers or supramolecular systems based on colloids, like micelles 
or liposomes (Fig. 1). Nanoscience is a highly interdisciplinary field as the study 
of the properties of nanomaterials covers materials science, chemistry, physics 
and biology. 
 Two contrasting methodologies to create nanostructures are the so-called 
“top-down” and the “bottom up” approaches (Fig. 2). In the “top-down” 
approach, a block of material is taken and carved away until the object that is 
wanted is reached using techniques such as engraving, photolithography or 
milling. Thus, the top down approach is based in using nanoengineering and 
erosion to form the nanomaterial [2]. 
 Instead, in the chemical approach (“bottom up”) [3], individual atoms 
and molecules are driven to or are placed precisely where they are needed by 
tools such as chemical synthesis, self-assembly or self-organisation. Therefore, 
supramolecular chemistry and the use of non-covalent interactions is the 
 
 
 
Figure 1. Size scale for different objects, including some soft materials within the 
nanoscale. 
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Figure 2. “Top-down” and “bottom up” approaches to the preparation of nanomaterials. 
 
driving force to the formation of nanomaterials [4] by such approach, which 
relies mainly on the molecular recognition between the molecular 
components forming the supramolecular aggregates. Examples of this 
approach expand from the natural world (assembling nucleic acids or 
molecular motors) to the synthetic one to define the nanochemistry universe 
(Fig. 3). 
 
 
 
Figure 3. “Bottom up” approach and its driving forces. 
 
 On the crossroads between nanotechnology and medicine arises the field 
of nanomedicine, which is mainly understood as the use of nanotechnological 
concepts to target medical problems [5]. It is also agreed that nanomedicine 
revolves around three main areas: medical diagnosis –including imaging-, 
tissue regeneration and drug delivery (Fig. 4) [6]. In this sense, it could be 
differentiated from nanobiotechnology because this discipline is more 
centered on developing basic research to biological systems at the nanoscale [5].  
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Figure 4. Applications of nanotechnology in medicine: Nanomedicine. 
 
 Beyond definitions, it is unarguable that both emerging fields are gaining 
much attention recently, and they rely on the use of nanostructured materials 
[7]. Thus, nanomaterials such as nanoparticles, nanofibers, nanowires and 
nanotubes have novel properties and functionalities which make them 
attractive to explore and modify biological processes, with potential 
applications in biomedicine [8]. Some of these nanomaterials are being 
envisaged and designed as multifunctional nanocarriers, aiming to perform 
functions as targeting, specific and selective delivering, and sensing [9]. 
Amongst them, nanoparticles used in drug delivery studies include liposomes, 
polymers, micelles, quantum dots, gold nanoparticles, paramagnetic 
nanoparticles and carbon nanotubes, although liposomes and micelles are so 
far the nanomaterials in clinical use (Fig. 5) [9,10]. 
 
 
 
Figure 5. Nanomaterials for Nanomedicine. 
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 In this review, and due to space limitations, a representative selection of 
examples was needed. Thus, considering the current research activity on this 
topic, and based in our own research experience, we have chosen some 
selected examples of the use of these nanomaterials, specifically gold 
nanoparticles, considered promising tools for both analytical purposes 
(diagnosis) and therapy (drug delivery). Additionally, we have included a 
section on self-assembled monolayers, as a representation of how powerful 
and relevant is surface chemistry for the preparation of functional 
nanomaterials and devices.  
 
1. Gold nanoparticles in Nanomedicine 
 
 The benefits of gold have been known for centuries both in medicine and 
art (Fig. 6). Its use as medicine has been documented as far as 2500 BC, in 
China [11]. In the 17th century, one of the most popular ways of obtaining 
medicinal gold in solution was by dissolving elemental gold in aqua regia 
[12]. However it was not until Faraday’s lecture, in 1857, that gold colloid 
was described as “diffused particles of gold”, in a thorough study of its 
properties, where he described the relationship between the various processes 
used to obtain gold in different states (including colloidal gold), the sizes of 
particles obtained, and their relation with the light [13]. 
 Recently, gold nanoparticles (GNPs) have been regarded with interest in 
the nanomedicine field as agents for labelling and imaging [14], diagnostic or 
carriers for delivery of biomolecules or small drugs, since they have               
many features that make them suitable for such applications. One that is of 
paramount importance is that the gold core is inert, and that GNPs, although  
 
 
 
Figure 6. The Lycurgus Cup (British Museum, London) made of dichroic glass, 
contains colloidal gold and silver that gives its property of being translucent when a 
light is shone through it. 
Oriol Penon et al.  6 
penetrating the cells, are mainly not cytotoxic. The degree of toxicity depends on 
the ligand that is stabilizing the gold core [15]. Also, is important the fact that 
they can be synthesized by simple methods that allow obtaining nanoparticles 
that are monodisperse, and the surface can be easily functionalized, mainly with 
thiols but also with others capping agents, such as amines [16], carboxylates [17], 
or phosphines [18]. There are many reviews focused on the applications of gold 
nanoparticles [19]. In the present review, we aim at giving a brief overview, with 
some recent examples found in scientific literature. 
 
1.1. Preparation methods 
 
 The most widely used methods for the synthesis of the GNPs are the 
citrate method, developed by Turkevich, and the Brust-Schiffrin method. In 
the first one, the gold salt HAuCl4 is reduced by citrate, which also has a 
stabilizing role [17]. Through this method, one can obtain GNPs that are 
water soluble, and varying the concentration of the reducing agent it is 
possible to tune the size of the particles. In the case of the Brust-Schiffrin 
method, the GNPs are obtained in a biphasic system [20]. In the organic 
phase there is a thiol, which acts as the capping agent that stabilizes and 
prevents the growth of the gold atom cluster. In the aqueous phase there is the 
reducing agent (sodium borohydride) and the gold salt HAuCl4. A phase 
transfer agent is needed, usually alkyl ammonium halides. The GNPs thus 
obtained are soluble in the organic phase. Since the surface of the GNP has a 
monolayer of the thiol attached, sometimes they are referred to as monolayer  
protected clusters (MPC). In literature, we can also find examples of GNPs 
that are stabilized by ionic liquids [21] and also gemini-type surfactants [22]. 
 Based in the Brust-Schiffrin biphasic system, our group developed a novel 
method for obtaining GNPs, using a bis-imidazolium amphiphile of gemini-type 
synthesized in our laboratory [23] (Fig. 7). This method proved to be suitable for 
obtaining GNPs that are monodisperse, able to enter cells, with low toxicity, that 
furthermore could be loaded with a model drug, pursuing its delivery (see below). 
 
 
 
Figure 7. Bis-imidazolium amphiphile 1·2Br (ref. [23]) and its distribution around the 
gold core of a gold nanoparticle. 
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1.2. Biomedical applications 
 
 GNPs suffer a phenomenon where the free electrons in the surface can 
absorb electromagnetic radiation, resulting in resonant oscillation. Due to this 
surface plasmon of the nanoparticles, i.e., propagating electron density waves 
occurring at the interface between metal and dielectric [14], they can be used 
as agents for labeling and imaging. 
 The Surface Plasmon Resonance (SPR) of the GNP can be used for 
diagnostic in Surface-enhanced Raman Scattering (SERS), which provides 
noninvasive in vivo imaging. The Plasmon resonance of the GNP increases the 
Raman effect of the molecules in the metal surface, with an increase in the signal 
by a factor of 1014-1015. Gold nanoparticles were used successfully to detect 
early-stage inflammatory processes through SERS. They were conjugated with 
monoclonal antibodies specific for intercellular adhesion molecule-1 (ICAM-1) 
[24]. The ICAM-1 expression in endothelial cells can be linked to the progression 
of a wide range of inflammatory, autoimmune and infectious diseases. The GNPs 
were tested in vitro and in vivo and showed an S/N ratio that was over 2-fold 
greater than the one obtained with another technique based in fluorescence 
microscopy. This approach could also be used in the imaging of cancer cells 
expressing specific markers. For example, gold nanorods (GNR) were conjugated 
with a specific antibody and were used to target HER2, a biomarker 
overexpressed in MCF7 breast cancer cells [25]. Other example used GNP 
conjugated with antibodies specific for different cancer biomarkers, namely 
HER2 (overexpressed in breast cancer cells) and EGFR (overexpressed in various 
cancers). The GNPs showed great stability and good results in vivo [26]. The 
SERS could also be used to monitor the release in the nanomolar range of 
thiopurine anticancer drugs from the GNP surface (Fig. 8) [27]. 
 
 
 
Figure 8. GNP with thiopurine on the surface. Inside the cells, the thiopurine is 
displaced from the surface by glutathione, it being released into solution, where its 
concentration can be monitored [27]. 
Oriol Penon et al.  8 
 GNPs are also being used as contrast agents for Magnetic Resonance 
Imaging (MRI). In many cases, the nanoparticles have a magnetic core (for 
example, Fe3O4) and a shell of Au that allows further functionalization with the 
desired molecule on the surface. This type of nanoparticles was studied for the 
diagnosis and therapy of prostate cancer [28]. The nanoparticles were 
conjugated with a monoclonal antibody specific for the prostate stem cell 
antigen that prostate cancer cells overexpress. The monoclonal antibody (mAb) 
targets the cancer cells, but it is also used in immunotherapy. MRI was used to 
assess in vivo biodistribution of the nanoparticles-mAb conjugate. Manganese-
gold nanoparticles are other example that is being studied. Mn2+ can be used as 
positive aqueous-based contrast agent for MRI imaging. These multifunctional 
Mn-GNPs were tested in vitro and ex vivo, and it was observed that they had 
low cell mortality and a high signal suitable for application in vivo [29]. Due to 
the versatility of these materials, alternatives are studied where the 
nanoparticles obtained can be used for both MRI and SERS [30]. In this case, 
the GNPs are complexed with iron oxide nanoparticles coated with dextran 
(Fig. 9). The dextran-iron oxide particles have already been studied as contrast 
agents for MRI, and the gold is deposited on its surface and functionalized with 
a reporter molecule that is used for detection through SERS. 
 Besides its use in imaging, GNPs can also be used as therapy agents, 
both alone, in photothermal therapy, or as drug delivery agents. In the first 
case, the photothermal therapy is based on the SPR of the GNP: when 
nanoparticles are irradiated with the adequate energy, they convert the light 
into heat that is responsible for the increase in the temperature, resulting in 
the ablation of the tumor [31]. Although the nanoparticles tend to accumulate 
in tumors (due to their high vascularization), the accumulation can be 
enhanced through the conjugation with ligands specific for the receptors that 
 
 
Figure 9. Iron oxide magnetic nanoparticles (MN) are covered with dextran. Gold 
nanoparticles (GNPs) are grown on its surface, and a thiol with PEG and a reporter 
molecule (DTTC) are attached [30]. 
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are overexpressed on the tumor cells. One example found in literature is the 
use of ephrinA1-conjugated nanoshells. This ligand is specific for the EphA2 
receptor that can be found in many prostate cancer cell lines. This approach 
was successfully used to target and destroy PC-3 prostate cancer cells in vivo, 
when a NIR laser was applied [32]. Similarly, colorectal tumors that overexpress 
guanylyl cyclase C (GCC) have been targeted through the conjugation of 
gold nanoshells with a heat-stable enterotoxin which is recognized by the 
receptor [33]. 
 The work we developed in our group with imidazolium based gold 
nanoparticles included the study of their potential as a drug delivery system 
[23]. In this particular case, the synthesized gold nanoparticles (Fig. 10) were 
successfully used to incorporate an anionic model drug (ibuprofenate) and 
deliver it in a sustained manner. Furthermore, the nanoparticles presented 
relatively low toxicity, and could be internalized by cells. 
 GNPs are also widely studied to be used as drug vectors. For example, 
some amino-glycosidic antibiotics (streptomycin, neomycin, gentamycin and 
kanamycin) were conjugated with BSA capped GNPs, and presented in vitro 
better antibacterial activity than the antibiotics alone [34]. In a similar way, 
the conjugation of oxaliplatin to GNPs showed an enhancement in the 
delivery of the drug to lung cancer cell line A549 and colon cancer cell lines 
HCT116, HCT15, HT29 and RKO, besides an increase in the penetration in 
 
 
Figure 10. a) Images of gemini-imidazolium stabilized gold nanoparticles in 
dichloromethane, and images of their b) UV-Vis absorption spectra; c) TEM 
micrograph, and d) TEM images of nanoparticles internalized in Caco-2 cells [23]. 
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the nucleus of the A549 cell line [35]. The enhancement can also be achieved 
through targeting, in the same way as described above for the GNPs used in 
imaging. For example, GNPs that were conjugated with curcumin, a potent 
anticancer molecule, and hyaluronic acid, which has strong affinity for cell 
surface markers CD44 and RHAMM. The markers are overexpressed in 
many types of tumors, probably because of the relation between hyaluronic 
acid and the angiogenesis.  Furthermore, the GNPs were conjugated also with 
folate-PEG, to enhance their targeting ability, which resulted in the desired 
intracellular accumulation of GNPs [36]. The same folate ligand was used in 
GNPs conjugated with doxorubicin for targeting and delivery to tumor cells. 
Testing in A549 (non-expressing folate receptor) and KB (expressing folate 
receptor) cell lines showed a doxorubicin intake higher than for the drug 
alone in both cell lines, but the uptake was higher in KB cell line due to the 
folate receptor [37]. Similarly, GNPs synthesized with a copolymer of 
aspartate-doxorubicin and PEG, and conjugated with folate showed a drug 
release made in a sustained manner, depending on the pH of the medium 
[38]; the release is faster in acidic medium due to the hydrolysis of the 
hydrazone linkage. GNPs functionalized with a thiol-PEG derivative of 
tamoxifen, which competes with 17β-estradiol for the estrogen receptor alfa 
(ERα), could be delivered selectively to breast cancer cells expressing ER, 
meaning that the receptor may aid the selectivity and uptake. The potency of 
the drug action in these breast cancer cells was up to 2.7 times higher [39]. 
GNPs covered with cyclodextrin, that provides a pocket to encapsulate                 
β-lapachone, an anticancer drug, and functionalized also with anti-EGFR 
antibody, for targeting, were developed. In this case, the release of 
cyclodextrin from the GNP is induced by the presence of glutathione, 
followed by the release of the drug from the cyclodextrin pocket [40]. In this 
case, the GNP has a targeting function besides the triggered release of the 
payload. 
 
1.3. Perspectives 
 
 Due to its versatility, GNPs are one of the nanostructured materials more 
widely studied, and has found application in distinct areas. Besides the    
given examples, the GNPs are also popular for use in diagnostic test kits.          
As outlined before, the examples shown here are just a small description. In 
the data below, one can see that the number of publications related with gold 
nanoparticles has seen an exponential increase (Fig. 11). 
 We expect to see very soon some of these systems clinically available, 
since they are being subject of active research in many fields, and show such 
promising results. 
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Figure 11. Number of publications with gold nanoparticles per year [41]. 
 
2. Self-assembled monolayers as (bio) sensors 
 
 Covalent immobilization of biomolecules or synthetic bioactive molecules 
onto solid supports is a key step in the area of biosensors, biotechnology and 
nanosciences [42]. One of the most currently used methods to immobilize 
biomolecules to substrates is the formation of an organic monolayer that will act 
as linker, the so-called self-assembled monolayer (SAM). SAMs are molecular 
assemblies formed spontaneously on metallic or inorganic surfaces by 
chemisorption between the substrate and a functional head group [43]. SAMs 
provide one simple route to functionalize surfaces by organic or biologic 
molecules containing free anchor groups such as thiols, disulfides, amines, 
silanes, or acids. The monolayer produced by self-assembly allows high 
flexibility with respect to several applications depending upon their terminal 
functionality or by varying the chain length (distance control). SAMs are also 
used as model substrates in biological studies because of their well-defined 
structure, controlled surface properties and biocompatibility. SAM formation 
allows the possibility of changing surface properties or to add new characteristics 
to the materials. The self-assembling molecules suitable to generate functional 
SAMs consist generally of three parts: the head group, the alkyl chain and the 
terminal end group (Fig. 12).  
 The head group is responsible for the anchoring of the molecules onto the 
substrate. The alkyl chain has a significant influence on the ordering of the 
SAM and provides the stability of the monolayer, due to van der Waals 
interactions. The terminal end group (functional group) introduces chemical 
functionality into the monolayer system and is important for the overall 
properties of surfaces because it allows the immobilization of the desired 
active molecule [44]. The control of chemical and physical properties of the  
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Figure 12. Fragments of functional SAMs. 
 
SAMs has recently gained considerable attention, since, by selecting 
precursor molecules with adequate terminal functional groups, the 
functionalities of these surfaces can be regulated at the nanoscale.  
 
2.1. SAMs formation and characterization 
  
 Different materials and assembling molecules have been employed as 
substrates for the formation of monolayers, but gold and silicon are the most 
widely used and studied because of the ease of using thiol and silane chains, 
respectively, to be attached onto the corresponding surfaces; they form well 
organized SAMs and they are biocompatible materials [45]. For example, 
SAM of long chain alkane thiol produces a highly packed and ordered 
surface, which can provide a membrane like microenvironment, useful for 
immobilizing biological molecules. 
 SAMs are formed spontaneously and can be produced usually through 
physical vapor deposition technique or by immersing a substrate into a 
solution of the molecule of interest (wet chemistry) [46]. SAM formation is a 
chemical process that depends on several parameters such as: deposition 
time, type of substrate and assembling molecule, type of solvent and 
deposition methodology. For example, to form a typical SAM on a gold 
surface, a diluted solution of the thiol in ethanol can be completed in less than 
1 h, although the SAM will be more ordered if the deposition time increases. 
Fig. 13 shows a schematic representation of the thiol formation on a gold 
surface. 
 The best option to have a good characterization of a SAM relies on the 
combination of several analytical techniques, which is essential in order to 
confirm the SAM formation and ensure its functionality. One of the most 
used techniques is Atomic Force Microscopy (AFM), a very high-resolution
Supramolecular chemistry for Nanomedicine   13 
 
 
 
Figure 13. Schematic representation of SAM formation on gold. 
 
type of scanning probe microscopy that allows the study of the surface 
coverage [47]. The information is obtained by "feeling" the surface with a 
piezoelectric (the cantilever), that explores the sample at the nanoscale with 
accurate and precise movements guided by a laser light from a solid state 
diode. 
 On the other hand, mass spectrometry techniques can be also used, such 
as matrix assisted laser desorption/ionization (MALDI-ToF MS), allowing 
the analysis of biomolecules and large organic molecules attached on the 
surface. MALDI MS has been used for SAM characterization first by 
Mrkisch, and it is used specially for gold surfaces because the fragmentation 
is lower and the total mass of the thiol can be detected [48]. Time of flight 
secondary ion mass spectrometry (Tof-SIMS MS) is a technique used to 
analyze the composition of solid surfaces, it being able to detect chemical 
elements or biological fragments such as amino acids [49]. Additionally,             
X-ray photoelectron spectroscopy (XPS) is a surface chemical analysis 
technique that allows the quantitative analysis of a material. XPS can 
measure the elemental composition, empirical formula and the chemical and 
electronic state of the elements present in a material [50]. 
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 Contact angle measurements are simple to make, and offer useful 
information about the hydrophobicity of a surface, and the changes that occur 
through surface modification. The method consists of depositing a drop of 
water on the functionalized surface and to record the angle formed between 
the drop and the surface [51]. Depending on the characteristics and the 
terminal group of the SAM, the hydrophobicity of the surface can be 
assessed. Fig. 14 shows an example of polysilicon functionalization 
methodology and the contact angle values associated to each chemical step. 
The initial polysilicon surface is quite hydrophobic (θ = 70º), but after 
hydroxylation the surface becomes highly hydrophilic (θ = 25º). Finally, 
when a SAM was formed using 11-triethoxysilaneundecanal (TESUD), the 
contact angle value increases noticeably, indicating the presence of the 
hydrophobic aldehyde SAM (θ = 98º) as well as a high level of surface 
functionalization. 
 
 
 
Figure 14. Contact angle measurements of clean polysilicon (θ = 70º), hydroxylated 
surface (θ = 25º) and TESUD monolayer (θ = 98º). 
 
2.2. Biomedical applications of SAMs 
 
 SAMs have been studied and investigated in the last decade for their       
high range of applications in many areas such as nanotechnology, chemical 
surface sciences, biotechnology, chemical engineering or electronics.                
The activity and the utility of the SAM depend on the molecule that will be 
immobilized into the SAM using the reactivity between the functional group 
of the SAM and the desired molecule [52].  
 Biofunctionalization of SAMs with different biomolecules is of great 
interest to give biological properties to the substrate, and the preparation of 
biosensors is one of the main applications of the biofunctionalized SAMs 
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[53]. The selectivity offered by biomolecules such as antibodies, proteins, 
nucleic acids and enzymes or even organised systems like whole cells can be 
profitably used for molecular recognition. As a consequence, immobilization 
strategies for biomolecules are of paramount importance in order to preserve 
their biological activity. Various types of immobilization procedures are able 
to link the biomolecule with the substrate. These procedures could be 
classified according to the covalent and non-covalent natures of the linkage 
[54], although the covalent bond is more used due to their strength and 
stability.  
 Proteins and other biomolecules can be covalently linked to SAMs via 
the N-terminal amino group [55]. Primary amines react with activated esters 
by nucleophilic attack resulting in the formation of an amide bond. As it has 
been reported in the literature, two classical ester activating groups, the 
tetrafluorophenyl ester (PFP) [56] and the N-hydroxysuccinimide (NHS) [57] 
can react readily with amine containing biomolecules to obtain an amide 
bound (Fig. 15a). Also, the aldehyde group can be used to attach 
biomolecules covalently to gold or silicon surfaces [58]. In this case, the 
amine groups in the biomolecule react with the aldehyde groups in the SAM 
to generate a stable secondary amine linkage by reduction of the intermediate 
imine (Fig. 15b).   
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Figure 15. Protein immobilization through a) amide bond and b) amine linkage. 
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 Examples of diagnosis systems based on SAMs are the personal glucose test 
devices or the pregnancy test kits [59]. Several biosensors also exist, of interest in 
Nanomedicine, based on the immobilization of antibodies or proteins that can 
recognize specific analytes. Fig. 16 shows an example of a protocol for the SAM 
formation on gold surface, followed by antibody immobilization and analyte 
testing for cancer detection [60]. First, a mixed SAM was structured using a) a 
terminal carboxylic acid thiol, which will react with the biomolecule, and b) a 
hydroxyl terminal thiol. The mixed thiols were chosen to provide appropriate 
organization and stability to the SAM, and to give the sufficient space to allow 
the active group to link the antibody.  Next, a classical acid activation was done 
using NHS and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) to 
connect the antibody covalently to the SAM. The immobilized antibody 
recognizes a specific antigen, thus acting as a nanobiosensor.  
 On the other hand, organic molecules can be also immobilized through a 
SAM. Normally, fluorescence moieties are included in the system, in order to 
detect changes depending on the parameter that has been studied [61]. The 
importance of sensing many biological processes has led to the development 
of fluorescence based organic receptors which can be used as chemosensors 
exhibiting a variation on their intrinsic fluorescence. The concept of                
organic receptor immobilization on functionalized substrates relies on 
detecting fluorescence changes in the presence of the given analyte (Fig. 17). 
 
 
 
Figure 16. Antibody functionalization example. 
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Figure 17. Model of fluorescence chemosensor. 
 
Supramolecular chemosensors are composed of a binding part for guest 
recognition, and a sensing moiety to read information about the complexation.  
 Immobilized chemosensors have been studied in the last years for 
sensing important biological parameters at cellular level such as biological 
ions or radicals as well as enzyme activity, using fluorescence changes 
because it is one of the preferred methods for detection in living organisms 
[62]. As example of chemosensor, one of the biological parameters that has 
been studied in the last years is the level of various reactive oxygen species 
(ROS), because they are implicated in many intracellular processes going from 
apoptosis or cellular activity to a variety of inflammatory responses [63].            
Fig. 18 shows a model of ROS sensor based on anthracene moieties [64]. 
 
 
 
Figure 18. ROS formation induces change on the fluorescence emission of the 
immobilized anthracene containing derivative. 
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 The presence of singlet oxygen detecting (1O2) produces the formation of 
an endoperoxide species, and the fluorescence of the complex increases.            
The system is hydrophilic, which is important for its use in biological 
samples, and furthermore, it is very selective for detecting 1O2. Therefore, 
appropriated SAMs can be used as fluorescent probes for recognizing 
specific analytes in a selective manner, with potential usefulness as sensors 
for biological systems. 
 SAMs were also used recently by us pursuing cell tracking, a promising 
approach to individual living cells identification. Silicon barcodes were designed 
for extracellular tagging using photolithography processes [65] and were 
modified using chemical biofunctionalization. A self-assembled monolayer was 
used as a connector between the silicon material and the lectin wheat germ 
aglutinin (WGA) [66]. WGA was used because of its capacity to recognize some 
specific carbohydrates present on the surface of most mammalian cells. SAMs 
were prepared on polysilicon surfaces including aldehyde groups as terminal 
functions to study the suitability of their covalent chemical bonding to WGA.        
Fig. 19 shows an outline of the biofunctionalized barcodes that were tested doing 
adhesion experiments to the zona pellucida of mouse embryos. These 
experiments showed high barcode retention rates after 96 h of culture as well as 
high viability indicating the robustness of the biofunctionalization. 
 
 
 
Figure 19. Representation of WGA biofunctionalized barcodes for embryo tagging. 
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3. Conclusion 
 
 We have shown various examples of nanomaterials of interest in 
Nanomedicine, mainly nanoparticles and self-assembled monolayers, some 
developed by our research group. The biofunctionality of any of the 
described nanomaterials is determined by a combination of an accurate 
design and selection of the components of the systems, as well as a                
shear control of the self-assembly processes governing their synthesis. 
Supramolecular chemistry lies behind any of these processes and it is central 
to any successful approach leading to new and promising nanomaterials for 
healthcare. 
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